{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:48Z","timestamp":1788922128521,"version":"build-2803163510"},"reference-count":54,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/501100011000","name":"Mission Interminist\u00e9rielle de Lutte contre les Addictions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use & Misuse"],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.1080\/10826084.2024.2434005","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T05:00:36Z","timestamp":1733806836000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Medications for Opioid Use Disorder in People Who Inject Substances: Reflection on the Potential Place of Morphine Sulfate as Substitution Treatment? Results of COSINUS Cohort Study"],"prefix":"10.1080","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7012-7037","authenticated-orcid":false,"given":"Laurence","family":"Lalanne","sequence":"first","affiliation":[{"name":"INSERM Unit 1329, STEP (Strasbourg Translationnal Neuroscience and Psychiatry)-CRBS (Centre de recherche en biom\u00e9decine de Strasbourg), Strasbourg"},{"name":"Department of Addictology, University Hospital of Strasbourg, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Ricardo","family":"Davalos","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00e9tude des mouvements sociaux (Inserm U1276, \/UMR CNRS 8044, \/EHESS\/Paris), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Audran","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00e9tude des mouvements sociaux (Inserm U1276, \/UMR CNRS 8044, \/EHESS\/Paris), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hamelin","sequence":"additional","affiliation":[{"name":"INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Chauvin","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00e9tude des mouvements sociaux (Inserm U1276, \/UMR CNRS 8044, \/EHESS\/Paris), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laelia","family":"Briand-Madrid","sequence":"additional","affiliation":[{"name":"Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Sant\u00e9 & Traitement de l\u2019Information M\u00e9dicale, Marseille, France"},{"name":"ORS PACA, Observatoire r\u00e9gional de la sant\u00e9 Provence-Alpes-C\u00f4te d\u2019Azur, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Kervran","sequence":"additional","affiliation":[{"name":"Univ. Bordeaux, INSERM, BPH, U1219, I-prev\/PHARES, Equipe Labellis\u00e9e Ligue Contre le Cancer, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Kirchherr","sequence":"additional","affiliation":[{"name":"INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Strasbourg, France"},{"name":"Department of Physiology and Pharmacology, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-8683","authenticated-orcid":false,"given":"Marc","family":"Auriacombe","sequence":"additional","affiliation":[{"name":"Department of psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Addiction Team (Laboratoire de psychiatrie)\/SANPSY, CNRS USR 3413, Bordeaux, France"},{"name":"P\u00f4le inter-\u00e9tablissement Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Roux","sequence":"additional","affiliation":[{"name":"Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Sant\u00e9 & Traitement de l\u2019Information M\u00e9dicale, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jauffret-Roustide","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00e9tude des mouvements sociaux (Inserm U1276, \/UMR CNRS 8044, \/EHESS\/Paris), Paris, France"},{"name":"British Columbia Center on Substance Use (BCCSU), Vancouver, Canada"},{"name":"Baldy Center on Law and Social Policy, Buffalo University, New York, USA"},{"name":"Institut interuniversitaire sur les dependances, Montr\u00e9al, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Cosinus Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023683"},{"key":"e_1_3_6_3_1","volume-title":"Citation","author":"Ball J. C.","year":"1991","unstructured":"Ball, J. C. (1991). The effectiveness of methadone maintenance. Patients, programs, services, and outcome. In J. C. Ball, & A. Ross, (eds.), Citation. Springer Verlag."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12440"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197601030-00004"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.893590"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00781-2"},{"key":"e_1_3_6_8_1","unstructured":"Brisacier A.-C. (2020). Tableau de bord \"Traitements de substitution aux opio\u00efdes\": Observatoire fran\u00e7ais des drogues et des tendances addictives 1\u201321."},{"key":"e_1_3_6_9_1","unstructured":"Cadet-Ta\u00efrou A. & Gandilhon M. (2014). L \u2018usage de sulfate de MS par les usagers de drogues en France. Tendances r\u00e9centes 2012\u20132013. Observatoire fran\u00e7ais des drogues et des tendances addictives 1\u201317."},{"key":"e_1_3_6_10_1","unstructured":"Circulaire n\u00b054 du 5 ao\u00fbt 1996 relative \u00e0 la prise en charge des traitements de substitution \u00e0 base de sulfate de MS pour les toxicomanes. (1996)."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0028-x"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(98)00028-3"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14791"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.03.002"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02720-8"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.001128.x"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544070-00001"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01271.x"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104487"},{"key":"e_1_3_6_20_1","unstructured":"European Monitoring Centre for Drugs Drug Addiction. (2012). New Heroin-Assisted Treatment\u2013Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond: EMCDDA Insights. LU Publications Office."},{"key":"e_1_3_6_21_1","unstructured":"European Monitoring Centre for Drugs Drug Addiction. (2018). PERSPECTIVES ON DRUGS: Drug consumption rooms: An overview of provision and evidence. 1\u20139."},{"key":"e_1_3_6_22_1","unstructured":"European Monitoring Centre for Drugs Drug Addiction. (2022). European Drug Report 2022: Trends and Developments."},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000288"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.017"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782"},{"key":"e_1_3_6_26_1","first-page":"1","article-title":"Drug-poisoning deaths involving heroin: United States, 2000-2013","volume":"190","author":"Hedegaard H.","year":"2015","unstructured":"Hedegaard, H., Chen, L. H., & Warner, M. (2015). Drug-poisoning deaths involving heroin: United States, 2000-2013. NCHS Data Brief, 190, 1\u20138.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004630-199403000-00002"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12564"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00592"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2016.03.011"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025799"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06683.x"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax9140"},{"key":"e_1_3_6_34_1","volume-title":"Buprenorphine. In: StatPearls","author":"Kumar R.","year":"2024","unstructured":"Kumar, R., Viswanath, O., & Saadabadi, A. (2024). Buprenorphine. In: StatPearls. StatPearls Publishing."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00170"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000396"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.11.002"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/286713"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711205010052"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00764.x"},{"key":"e_1_3_6_41_1","unstructured":"Ndiaye A. (2023). Traitements de substitution aux opio\u00efdes en France. Bilan 2023. OFDT 1\u201314."},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306763"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14886"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.06.013"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.12.024"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082410"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2049-0801(12)70013-4"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100557"},{"issue":"2","key":"e_1_3_6_50_1","first-page":"17","article-title":"The role and function of heroin assisted treatment at the treatment system level","volume":"19","author":"Uchtenhagen A.","year":"2017","unstructured":"Uchtenhagen, A. (2017). The role and function of heroin assisted treatment at the treatment system level. Heroin Addiction and Related Clinical Problems, 19(2), 17\u201324.","journal-title":"Heroin Addiction and Related Clinical Problems,"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102934"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000368572"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2015.10.003"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.91934"}],"container-title":["Substance Use & Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2024.2434005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T15:49:31Z","timestamp":1737906571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2024.2434005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2,23]]}},"alternative-id":["10.1080\/10826084.2024.2434005"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2024.2434005","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}